Loading...
Search for: malignant-neoplasm
0.01 seconds

    Virotheranostics, a double-barreled viral gun pointed toward cancer; Ready to shoot?

    , Article Cancer Cell International ; Volume 20, Issue 1 , 2020 Keshavarz, M ; Sabbaghi, A ; Miri, S. M ; Rezaeyan, A ; Arjeini, Y ; Ghaemi, A ; Sharif University of Technology
    BioMed Central Ltd  2020
    Abstract
    Compared with conventional cancer treatments, the main advantage of oncolytic virotherapy is its tumor-selective replication followed by the destruction of malignant cells without damaging healthy cells. Accordingly, this kind of biological therapy can potentially be used as a promising approach in the field of cancer management. Given the failure of traditional monitoring strategies (such as immunohistochemical analysis (in providing sufficient safety and efficacy necessary for virotherapy and continual pharmacologic monitoring to track pharmacokinetics in real-time, the development of alternative strategies for ongoing monitoring of oncolytic treatment in a live animal model seems... 

    Immunomodulating hydrogels as stealth platform for drug delivery applications

    , Article Pharmaceutics ; Volume 14, Issue 10 , 2022 ; 19994923 (ISSN) Rezaei, Z ; Yilmaz Aykut, D ; Tourk, F. M ; Bassous, N ; Barroso Zuppa, M ; Shawl, A. I ; Ashraf, S. S ; Avci, H ; Hassan, S ; Sharif University of Technology
    MDPI  2022
    Abstract
    Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effective in vivo treatment. Hydrogels are excellent candidates that can be engineered to control immune responses by modulating biomolecule release/adsorption, improving regeneration of lymphoid tissues, and enhancing function during antigen presentation. This review discusses the aspects of hydrogel-based systems used as drug delivery platforms for various diseases. A detailed investigation on... 

    Iran in transition

    , Article The Lancet ; Volume 393, Issue 10184 , 2019 , Pages 1984-2005 ; 01406736 (ISSN) Danaei, G ; Farzadfar, F ; Kelishadi, R ; Rashidian, A ; Rouhani, O. M ; Ahmadnia, S ; Ahmadvand, A ; Arabi, M ; Ardalan, A ; Arhami, M ; Azizi, M. H ; Bahadori, M ; Baumgartner, J ; Beheshtian, A ; Djalalinia, S ; Doshmangir, L ; Haghdoost, A. A ; Haghshenas, R ; Hosseinpoor, A. R ; Islami, F ; Kamangar, F ; Khalili, D ; Madani, K ; Masoumi Asl, H ; Mazyaki, A ; Mirchi, A ; Moradi, E ; Nayernouri, T ; Niemeier, D ; Houshang Omidvari, A ; Peykari, N ; Pishgar, F ; Qorbani, M ; Rahimi, K ; Rahimi Movaghar, A ; Ramezani Tehrani, F ; Rezaei, N ; Shahraz, S ; Takian, A ; Tootee, A ; Ezzati, M ; Jamshidi, H. R ; Larijani, B ; Majdzadeh, R ; Malekzadeh, R ; Sharif University of Technology
    Lancet Publishing Group  2019
    Abstract
    Being the second-largest country in the Middle East, Iran has a long history of civilisation during which several dynasties have been overthrown and established and health-related structures have been reorganised. Iran has had the replacement of traditional practices with modern medical treatments, emergence of multiple pioneer scientists and physicians with great contributions to the advancement of science, environmental and ecological changes in addition to large-scale natural disasters, epidemics of multiple communicable diseases, and the shift towards non-communicable diseases in recent decades. Given the lessons learnt from political instabilities in the past centuries and the... 

    Stimulus-responsive sequential release systems for drug and gene delivery

    , Article Nano Today ; Volume 34 , 2020 Ahmadi, S ; Rabiee, N ; Bagherzadeh, M ; Elmi, F ; Fatahi, Y ; Farjadian, F ; Baheiraei, N ; Nasseri, B ; Rabiee, M ; Tavakoli Dastjerd, N ; Valibeik, A ; Karimi, M ; Hamblin, M. R ; Sharif University of Technology
    Elsevier B.V  2020
    Abstract
    In recent years, a range of studies have been conducted with the aim to design and characterize delivery systems that are able to release multiple therapeutic agents in controlled and programmed temporal sequences, or with spatial resolution inside the body. This sequential release occurs in response to different stimuli, including changes in pH, redox potential, enzyme activity, temperature gradients, light irradiation, and by applying external magnetic and electrical fields. Sequential release (SR)-based delivery systems, are often based on a range of different micro- or nanocarriers and may offer a silver bullet in the battle against various diseases, such as cancer. Their distinctive... 

    Graphene aerogel nanoparticles for in-situ loading/pH sensitive releasing anticancer drugs

    , Article Colloids and Surfaces B: Biointerfaces ; Volume 186 , 2020 Ayazi, H ; Akhavan, O ; Raoufi, M ; Varshochian, R ; Hosseini Motlagh, N. S ; Atyabi, F ; Sharif University of Technology
    Elsevier B.V  2020
    Abstract
    Free polymer graphene aerogel nanoparticles (GA NPs) were synthesized by using reduction/aggregation of graphene oxide (GO) sheets in the presence of vitamin C (as a biocompatible reductant agent) at a low temperature (40 °C), followed by an effective sonication. Synthesis of GA NPs in doxorubicin hydrochloride (DOX)-containing solution results in the simultaneous synthesis and drug loading with higher performance (than that of the separately synthesized and loaded samples). To investigate the mechanism of loading and the capability of GA NPs in the loading of other drug structures, two groups of ionized (DOX, Amikacin sulfate and, D-glucosamine hydrochloride) and non-ionized (Paclitaxel... 

    Oncolytic newcastle disease virus delivered by mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment

    , Article Virology Journal ; Volume 17, Issue 1 , 2020 Keshavarz, M ; Ebrahimzadeh, M. S ; Miri, S. M ; Dianat Moghadam, H ; Ghorbanhosseini, S. S ; Mohebbi, S. R ; Keyvani, H ; Ghaemi, A ; Sharif University of Technology
    BioMed Central Ltd  2020
    Abstract
    Background: Human papillomavirus (HPV)-associated malignancy remain a main cause of cancer in men and women. Cancer immunotherapy has represented great potential as a new promising cancer therapeutic approach. Here, we report Mesenchymal stem cells (MSCs) as a carrier for the delivery of oncolytic Newcastle disease virus (NDV) for the treatment of HPV-associated tumor. Methods: For this purpose, MSCs obtained from the bone marrow of C57BL mice, then cultured and characterized subsequently by the flow cytometry analysis for the presence of cell surface markers. In this study, we sought out to determine the impacts of MSCs loaded with oncolytic NDV on splenic T cell and cytokine immune... 

    CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

    , Article Cancer Cell International ; Volume 20, Issue 1 , September , 2020 Miri, S. M ; Tafsiri, E ; Cho, W. C. S ; Ghaemi, A ; Sharif University of Technology
    BioMed Central Ltd  2020
    Abstract
    Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients, a so called "adoptive cell transfer", or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell... 

    Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes

    , Article AAPS Journal ; Volume 19, Issue 3 , 2017 , Pages 652-668 ; 15507416 (ISSN) Morales, J. O ; Fathe, K. R ; Brunaugh, A ; Ferrati, S ; Li, S ; Montenegro Nicolini, M ; Mousavikhamene, Z ; McConville, J. T ; Prausnitz, M. R ; Smyth, H. D. C ; Sharif University of Technology
    Springer New York LLC  2017
    Abstract
    Biologic products are large molecules such as proteins, peptides, nucleic acids, etc., which have already produced many new drugs for clinical use in the last decades. Due to the inherent challenges faced by biologics after oral administration (e.g., acidic stomach pH, digestive enzymes, and limited permeation through the gastrointestinal tract), several alternative routes of administration have been investigated to enable sufficient drug absorption into systemic circulation. This review describes the buccal, sublingual, pulmonary, and transdermal routes of administration for biologics with relevant details of the respective barriers. While all these routes avoid transit through the...